Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-048728

Options or other derivatives

  • CEO acquired 25,470,215 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pershing Edward CEO 2024-12-02 Grant or award · Stock Options (Right to Buy) +25,470,215 25,470,215 D
Loading xslF345X05/ownership.xml…